NCT03172871View on ClinicalTrials.gov

Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

436

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

July 22, 2019

Study Completion Date

September 30, 2019

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole IM Depot

Aripiprazole IM depot 400 mg/300 mg (when not tolerated)

DRUG

Aripiprazole tablet

Oral aripiprazole tablets 10 to 20 mg daily

Trial Locations (1)

100088

Beijing Anding Hospital of Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY